Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate 68Ga-N188 PET/CT Imaging of Nectin-4 Expression in Malignant Tumors

NCT05593107 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT05593107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05593107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate 68Ga-N188 PET/CT Imaging of Nectin-4 Expression in Malignant Tumors
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
August 12, 2022
Completion date
July 31, 2025
Enrollment
203 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms